Document is current
Any future updates will be listed below
-
Authors
Lim, Endry H. T.
Vlaar, Alexander P. J.
Bos, Lieuwe D. J.
van Vught, Lonneke A.
Boer, Anita M. Tuip-de
Dujardin, Romein W. G.
Habel, Maria
Xu, Zhongli
Brouwer, Matthijs C.
van de Beek, Diederik
de Bruin, Sanne
,
van Agtmael, Michiel
Algera, Anne Geke
Appelman, Brent
van Baarle, Floor
Beudel, Martijn
Bogaard, Harm Jan
Bomers, Marije
Bonta, Peter
Bos, Lieuwe D. J.
Botta, Michela
de Brabander, Justin
Bree, Godelieve
Bugiani, Marianna
Bulle, Esther
Chouchane, Osoul
Cloherty, Alex
Buis, David T. P.
de Rotte, Maurits C. F. J.
Dijkstra, Mirjam
Dongelmans, Dave A.
Elbers, Paul
Fleuren, Lucas
Geerlings, Suzanne
Geijtenbeek, Theo
Girbes, Armand
Goorhuis, Bram
Grobusch, Martin P.
Hagens, Laura
Hamann, Jorg
Harris, Vanessa
Hemke, Robert
Hermans, Sabine M.
Heunks, Leo
Hollmann, Markus
Horn, Janneke
Hovius, Joppe W.
de Jong, Menno D.
Koning, Rutger
van Mourik, Niels
Nellen, Jeannine
Nossent, Esther J.
Paulus, Frederique
Peters, Edgar
Piña-Fuentes, Dan A. I.
van der Poll, Tom
Preckel, Bennedikt
Prins, Jan M.
Raasveld, Jorinde
Reijnders, Tom
Schinkel, Michiel
Schrauwen, Femke A. P.
Schultz, Marcus J.
Schuurman, Alex
Schuurmans, Jaap
Sigaloff, Kim
Slim, Marleen A.
Smeele, Patrick
Smit, Marry
Stijnis, Cornelis S.
Stilma, Willemke
Teunissen, Charlotte
Thoral, Patrick
Tsonas, Anissa M.
Tuinman, Pieter R.
van der Valk, Marc
Veelo, Denise
Volleman, Carolien
de Vries, Heder
van Vugt, Michèle
Wouters, Dorien
Zwinderman, Aeilko H.
Wiersinga, W. Joost
-
Funding
Funding for this research was provided by:
InflaRx
Dr. C.J. Vaillant Fonds
Amsterdam UMC Corona Research Fund
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 5 December 2022
First Online: 24 December 2022
Declarations
:
: The protocol of the phase 2 PANAMO trial was approved by the medical research ethics committee of the Amsterdam UMC, location AMC (IRB 2020_067#B2020179). The Amsterdam UMC COVID-19 Biobank study was approved by the biobank ethics committees of Amsterdam UMC (2020_065). All patients or their legally authorised representatives provided written informed consent to participate in the study. Patients could be included with deferred consent if direct informed consent of patients was not possible.
: All patients or their legally authorised representatives provided written informed consent for publication.
: Prof. Dr. Vlaar reports personal fees from InflaRx paid to Amsterdam UMC, during conduct of the study. Dr. Habel and Dr. Xu are employees of InflaRx. All other authors declare no competing interests.
